Brind.
  1. Evotec, Bristol Myers Squibb, and Sandoz announced the evolution of their strategic partnership and financial results from Hamburg.

Sandoz and Evotec announced a strategic partnership and potential sale of the Just - Evotec Biologics EU site in Toulouse.

1 report, 1 independent Updated Jul 30
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Sandoz and Evotec announced a strategic partnership and potential sale of the Just - Evotec Biologics EU site in Toulouse.

Who's involved

What this event is mainly about
SandozEvotec

How it developed

Newest first. Tap a step to see who reported it.
  1. Sandoz is facing issues regarding the absence of licensing payments related to the strategic partnership with Evotec.Sub-event
  2. Sandoz assumes full ownership of the Evotec Biologics site in Toulouse.Sub-event
  3. The partnership includes the potential sale of the Just - Evotec Biologics EU site in Toulouse.1 source

Keep exploring

Part of

Evotec, Bristol Myers Squibb, and Sandoz announced the evolution of their strategic partnership and financial results from Hamburg. All 2 developments

The entities involved

Coverage

Newest first; wire copies grouped
  • ACCESS NewswireEvotec and Sandoz Evolve their Strategic Partnership and Agree on Potential Sale of Just - Evotec Biologics Toulouse Site Evotec SE and Sandoz AG signed a non-binding term sheet on a planned sale of